CClinicalTrials.gg
CompletedNCT05184972Updated Sep 7, 2023

Coverage and Validity of the Swedish Registry of Cardiopulmonary Resuscitation Regarding In-hospital Cardiac Arrest

An observational study in In-hospital Cardiac Arrest, sponsored by Dalarna University. Completed at 1 site in Sweden. Open to participants aged 29 Days and older. Per ClinicalTrials.gov, last updated 2023-09-07.

Sponsored by Dalarna University · Observational

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
1,109
Ages
29 Days and older
Sex
All
01

Study summary

The study will have an observational retrospective cross-sectional design. Patient records and hospital administrative systems at 10 hospitals in Sweden will be searched using ICD-codes to find all patients treated for an in-hospital cardiac arrest (IHCA) during the time period of 20180101 to 20191231. All found patients will be cross-checked against reported patients in the Swedish Registry of Cardiopulmonary Resuscitation (SRCR). Any differences in patient characteristics or regarding situation factors between reported and non-reported patients will be evaluated. Non-reported patients will be retrospectively reported to the registry. An incidence of IHCA will be calculated using the number of patients treated for IHCA divided by number of hospital admissions during the specific time period. Selected variables will be evaluated regarding compliance to report and regarding concordance with patient records. All missing data will be described and evaluated. Local reporting procedures at each hospital will be described and evaluated regarding compliance to report and regarding missing data.

02

Conditions studied

  • In-hospital Cardiac Arrest

Browse trials for

03

In context

Heart Arrest

966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

This study's enrollment of 1,109 is above the median of 200 across 383 observational studies indexed under Heart Arrest.

Browse Heart Arrest studies →

Lead sponsor

Dalarna University is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
29 Days and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

An in-hospital cardiac arrest is defined as an arrest that occurs in a hospitalized patient who had a pulse at the time of admission. A hospital is defined as a facility with twenty-four hours a day care including an intensive care unit and an emergency team. Treatment of a cardiac arrest involves initiation of CPR or defibrillation. Data of patients treated for in-hospital cardiac arrest will be collected from 10 hospitals of varying size during 20180101 to 20191231 in Sweden. Data of reported patients treated for in-hospital cardiac arrest during the same time period at each hospital will be extracted from the SRCR .

Inclusion criteria

  • All patients after the neonatal period that have been treated for an in-hospital cardiac arrest.

Exclusion criteria

Exclusion Criteria:

  • Patients with an in-hospital cardiac arrest that is not treated (do not attempt resuscitation) or patients in the neonatal period.
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
1,109 participants (actual)
Patient registry
No

Groups and cohorts

  • Non-reported patients treated for in-hospital cardiac arrest
  • Reported patients treated for in-hospital cardiac arrest
06

What researchers measure

Primary outcomes

  1. Proportion of reported patients treated for in-hospital cardiac arrest

    To evaluate the proportion of patients treated for in-hospital cardiac arrest that are reported to the SRCR

    Time frame: During hospital stay (retrospective observation january 1 2018 to december 31 2019)

Secondary outcomes

  1. Incidence of in-hospital cardiac arrest

    To calculate an incidence of number of patients treated for in-hospital cardiac arrest based on number of hospital admissions during a specific time period.

    Time frame: During hospital stay (retrospective observation january 1 2018 to december 31 2019)

  2. Patient characteristics

    To evaluate possible differences in patient characteristics or situation factors between reported and non-reported patients treated for in-hospital cardiac arrest.

    Time frame: During hospital stay (retrospective observation january 1 2018 to december 31 2019)

Other outcomes

  1. Reporting procedures at hospitals

    To describe reporting procedures at each hospital in relation to coverage of patients treated for in-hospital cardiac arrest.

    Time frame: At study start (interview with CPR coordinators)

07

Study locations

1 site
  • Registercentrum Västra Götaland
    Gothenburg, Sweden
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05184972
Lead sponsor
Dalarna University
Collaborators
Dalarna County Council, Sweden
Responsible party
Jennie Silverplats (PhD student, Dalarna University) — Principal investigator
First posted
Jan 11, 2022
Start date
Mar 10, 2022
Primary completion
Jun 12, 2023
Completion
Sep 6, 2023
Last update
Sep 7, 2023

Study contacts

Anneli Strömsöe, PhD
principal investigator · Dalarna University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion